ProCE Banner Activity

American Psychiatric Association (APA) Clinical Practice Guidelines on Tardive Dyskinesia Management in Patients With Schizophrenia

Clinical Thought
The burden of schizophrenia and tardive dyskinesia is extensive. In this expert commentary, Martha Sajatovic, MD, explores the American Psychiatric Association 2021 practice guidelines on tardive dyskinesia management in schizophrenia and the advancements in pharmacologic and psychosocial treatments.

Released: February 07, 2022

Expiration: February 06, 2023

No longer available for credit.

Share

Faculty

Martha Sajatovic

Martha Sajatovic, MD

Professor of Psychiatry and of Neurology
Willard Brown Chair in Neurological Outcomes Research
Rocco L. Motto Professorship in Child & Adolescent Psychiatry
Director, Neurological and Behavioral Outcomes Center
University Hospitals Cleveland Medical Center
Case Western Reserve University School of Medicine
Cleveland, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant provided by

Neurocrine Biosciences

Faculty Disclosure

Primary Author

Martha Sajatovic, MD

Professor of Psychiatry and of Neurology
Willard Brown Chair in Neurological Outcomes Research
Rocco L. Motto Professorship in Child & Adolescent Psychiatry
Director, Neurological and Behavioral Outcomes Center
University Hospitals Cleveland Medical Center
Case Western Reserve University School of Medicine
Cleveland, Ohio

Martha Sajatovic, MD, has disclosed that she has received research funds from Alkermes, Nuromate, and Otsuka; has received consulting fees from Alkermes, Health Analytics, Janssen, Myriad, and Otsuka.